Personal Information
Entreprise/Lieu de travail
Korea Korea, South
Profession
Regulatory Affairs Team Manager at Kowa Korea Company, RAC
Secteur d’activité
Medical / Health Care / Pharmaceuticals
À propos
An expert of regulatory affairs in pharmaceutical industry with more than 15 years of experience, and wide range of experience at the various organizations including Health Authorities (KFDA, MOHW), KPA (Korea Pharmacist Association), local pharmaceutical company (Yuhan Corporation) and multinational companies (BMS Korea, Korea Otsuka Pharmaceutical, Kowa Korea).
Regulatory Affairs Certified (RAC) by Regulatory Affairs Professional Society (RAPS) in 2014.
Specialties: Making new drug's development strategy, NDA process (Dossier preparation, submission, and approval of ETC & OTC drug and others), and IND process (multinational clinical trials IND dossier preparation, submission, and appr...
J’aime
(3)Confused by FDA Guidance on Standardized Study Data for Electronic Submissions?
Brook White, PMP
•
il y a 8 ans
USFDA NDA Vs BLA
Girish Swami
•
il y a 10 ans
Pharma regulatory affairs
Girish Swami
•
il y a 11 ans
Personal Information
Entreprise/Lieu de travail
Korea Korea, South
Profession
Regulatory Affairs Team Manager at Kowa Korea Company, RAC
Secteur d’activité
Medical / Health Care / Pharmaceuticals
À propos
An expert of regulatory affairs in pharmaceutical industry with more than 15 years of experience, and wide range of experience at the various organizations including Health Authorities (KFDA, MOHW), KPA (Korea Pharmacist Association), local pharmaceutical company (Yuhan Corporation) and multinational companies (BMS Korea, Korea Otsuka Pharmaceutical, Kowa Korea).
Regulatory Affairs Certified (RAC) by Regulatory Affairs Professional Society (RAPS) in 2014.
Specialties: Making new drug's development strategy, NDA process (Dossier preparation, submission, and approval of ETC & OTC drug and others), and IND process (multinational clinical trials IND dossier preparation, submission, and appr...